Akbari A, Mobini GR, Agah S, Morvaridzadeh M, Omidi A, Potter E, Fazelian S, Ardehali SH, Daneshzad E, Dehghani S
Hold the button down and leave the needle in your skin for 6 seconds to make sure you get the full dose
The Phase 2 trial showed 22.8% average body weight reduction at 48 weeks in the 8mg group
A two-component co-formulation of Cagrilintide and a GLP-1class peptide supplied for controlled research environments
The composition of the present invention should preferably have a unit dosage form containing the pharmacologically active BPC peptide salt of the invention and, if necessary, together with further additives such as the abovementioned water-soluble protein
However, it is essential to follow any specific fasting instructions provided by your healthcare provider if necessary for certain treatments.